Indomethacin (Compound)

Synonyms:indomethacin, 53-86-1, indometacin, Indocin, Indomethacine, Indometacine, Indocid, Metindol, Reumacide, Indomethazine, Imbrilon, Amuno, Tannex, Indomethacinum, Artracin, Artrinovo, Artrivia, Confortid, Idomethine, Indomecol, Indoptic, Indoptol, Inflazon, Infrocin, Metartril, Methazine, Mikametan, Sadoreum, Dolovin, Inacid, Indacin, Indomed, Indomee, Lausit, Metacen, Mobilan, Indo-rectolmin, Indo-tablinen, Inteban sp, Durametacin, Indometacyna, Indometicina, Mezolin, Indo-Lemmon, Indometacinum, 2-(1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid, Indometacina, Dolcidium, Elmetacin, Indomethine, Indorektal, Aconip, Catlep, Indoxen, Vonum, Indo-phlogont, Chibro-amuno, Rheumacin LA, 1H-Indole-3-acetic acid, 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-, Osmosin, Tivorbex, 1-(p-Chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid, CCRIS 3502, 2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetic acid, HSDB 3101, 1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-3-indoleacetic acid, NCI-C56144, MFCD00057095, Indometacin [INN], Indomethacin (Indocid, Indocin), CHEMBL6, 1-(p-Chlorobenzoyl)-2-methyl-5-methoxyindole-3-acetic acid, IMN, Indole-3-acetic acid, 1-(p-chlorobenzoyl)-5-methoxy-2-methyl-, NSC-757061, 1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid, Indocin Sr, XXE1CET956, 2-{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1h-indol-3-yl}acetic acid, N-p-Chlorbenzoyl-5-methoxy-2-methylindole-3-acetic acid, MLS000069402, DTXSID9020740, (1-p-Chlorobenzoyl-5-methoxy-2-methylindol-3-yl)acetic acid, CHEBI:49662, 1-(p-Chlorobenzoyl)-2-methoxy-3-methyl-1H-indole-3-acetic Acid, Indomet 140, [1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetic acid, alpha-(1-(p-Chlorobenzoyl)-2-methyl-5-methoxy-3-indolyl)acetic acid, NSC-77541, CAS-53-86-1, 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico, NCGC00015562-18, Indmethacine, Indomethancin, 1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indolylacetic acid, Arthrexin, Bonidin, Bonidon, Indameth, Indomod, Miametan, SMR000058195, Indomo, Flexin continus, Hicin, Kwas 1-(p-chlorobenzoilo)-2-metylo-5-metoksy-3-indolilooctowy, Chrono-indicid, Chrono-indocid, Indometacyna [Polish], Bonidon Gel, Indometicina [Spanish], 2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetic acid, Dolcidium PL, Indo-Spray, Indolar SR, {1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid, DTXCID50740, Indometacine [INN-French], Indometacinum [INN-Latin], Indometacina [INN-Spanish], 1-(4-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid, 1-(p-Chlorobenzoyl)-5-methoxy-2-methyl-Indole-3-acetic acid, 2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-indol-3-yl]acetic acid, 2-{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methylindol-3-yl}acetic acid, Indocin-SR, Indochron E-R, Indocin (TN), Aconip (TN), Indomethacin (USP), FLAM, Indocid (pharmaceutical), SR-01000000014, EINECS 200-186-5, Indomethacin & MAP-30, Indomethacin [USAN:USP], UNII-XXE1CET956, BRN 0497341, Indocollyre, Indonol, Innamit, Inteban, (1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYL-1H-INDOL-3-YL)ACETIC ACID, 2-{1-((4-chlorophenyl)carbonyl)-5-methoxy-2-methylindol-3-yl}acetic acid, 4kyk, Indomethacin,(S), Prestwick_597, Opera_ID_56, Spectrum_000919, Tocris-1708, 1z9h, 1-(p-Chlorbenzoyl)-5-methoxy-2-methylindol-3-essigsaeure [German], 1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish], Prestwick0_000272, Prestwick1_000272, Prestwick2_000272, Prestwick3_000272, Spectrum2_000970, Spectrum3_000468, Spectrum4_000018, Spectrum5_000868, INDOMETACIN [JAN], INDOMETHACIN [MI], Lopac-I-7378, Kwas 1-(p-chlorobenzoilo)-2-metylo-5-metoksy-3-indolilooctowy [Polish], MolMap_000032, UPCMLD-DP023, EC 200-186-5, I 7378, Indometacin (JP17/INN), INDOMETHACIN [HSDB], INDOMETHACIN [USAN], SCHEMBL9300, INDOMETACIN [MART.], INDOMETHACIN [VANDF], Lopac0_000692, Oprea1_686105, BSPBio_000144, BSPBio_001149, BSPBio_002176, INDOMETACIN [WHO-DD], INDOMETACIN [WHO-IP], Indomethacine impurity mixture, KBioGR_000395, KBioGR_000489, KBioSS_000489, KBioSS_001399, 5-22-05-00239 (Beilstein Handbook Reference), MLS001074194, MLS006011845, BIDD:GT0132, DivK1c_000271, INDOMETHACIN [USP-RS], SPECTRUM1500350, SPBio_000979, SPBio_002363, BPBio1_000160, GTPL1909, Indomethacin, >=99% (TLC), UPCMLD-DP023:001, BDBM17638, CGIGDMFJXJATDK-UHFFFAOYSA-, HMS500N13, KBio1_000271, KBio2_000489, KBio2_001399, KBio2_003057, KBio2_003967, KBio2_005625, KBio2_006535, KBio3_000897, KBio3_000898, KBio3_001396, 1-(p-Chlorbenzoyl)-5-methoxy-2-methylindol-3-essigsaeure, Indomethacin - CAS 53-86-1, NINDS_000271, Bio2_000405, Bio2_000885, HMS1362I11, HMS1568H06, HMS1792I11, HMS1920F21, HMS1990I11, HMS2089N19, HMS2091N09, HMS2095H06, HMS2231J10, HMS3262K05, HMS3268A14, HMS3374F07, HMS3403I11, HMS3414N13, HMS3430L03, HMS3649K17, HMS3655O04, HMS3678N11, HMS3712H06, HMS3747K21, HMS3884E08, INDOMETACIN [EP MONOGRAPH], INDOMETHACIN [ORANGE BOOK], Indomethacin-d4(chlorobenzoyl-d4), Pharmakon1600-01500350, ACT02579, BCP18951, Indomethacin, >=99.0% (TLC), INDOMETHACIN [USP MONOGRAPH], Tox21_113109, Tox21_201791, Tox21_300266, Tox21_500692, AC-532, CCG-40186, HB4422, INDOMETACINUM [WHO-IP LATIN], NSC757061, s1723, STL257874, AKOS000592893, Tox21_113109_1, AT13679, DB00328, Indometacin 1.0 mg/ml in Acetonitrile, KS-5255, LP00692, NSC 757061, SDCCGSBI-0050670.P005, IDI1_000271, IDI1_002160, NCGC00015562-01, NCGC00015562-02, NCGC00015562-03, NCGC00015562-04, NCGC00015562-05, NCGC00015562-06, NCGC00015562-07, NCGC00015562-08, NCGC00015562-09, NCGC00015562-10, NCGC00015562-11, NCGC00015562-12, NCGC00015562-13, NCGC00015562-14, NCGC00015562-15, NCGC00015562-16, NCGC00015562-17, NCGC00015562-19, NCGC00015562-20, NCGC00015562-21, NCGC00015562-22, NCGC00015562-24, NCGC00015562-25, NCGC00015562-40, NCGC00024135-02, NCGC00024135-04, NCGC00024135-05, NCGC00024135-06, NCGC00024135-07, NCGC00024135-08, NCGC00024135-09, NCGC00024135-10, NCGC00024135-11, NCGC00024135-12, NCGC00024135-13, NCGC00024135-14, NCGC00024135-15, NCGC00254075-01, NCGC00259340-01, NCGC00261377-01, BI166166, BP-30207, HY-14397, NCI60_041708, SBI-0050670.P004, ACEMETACIN IMPURITY B [EP IMPURITY], DB-052413, AB00052022, EU-0100692, FT-0603227, I0655, SW196768-5, EN300-16807, Indomethacin, meets USP testing specifications, BIM-0050670.0001, C01926, D00141, S00108, AB00052022-20, AB00052022-21, AB00052022_23, AB00052022_24, L000959, Q409231, Indomethacin, Antibiotic for Culture Media Use Only, Q-201239, SR-01000000014-2, SR-01000000014-4, SR-01000000014-6, 1-(4-Chlorobenzoyl)-5-methoxy-2-met hyl-1H-indole, BRD-K57222227-001-06-1, BRD-K57222227-001-18-6, BRD-K57222227-001-27-7, SR-01000000014-10, SR-01000000014-16, Z56784896, 1-p-chlorobenzoyl-2-methyl-5-methoxyindol-3-acetic acid, 1-(p-chlorobenzoyl)-2-methyl-5-methoxy-3-indoleacetic acid, 1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indoleacetic acid, 1-(p-Chlorobenzoyl)-5-methoxy-2-methylindol-3-acetic acid, 1-(4-chloro-benzoyl)-5-methoxy-2-methyl-3-indolyl-acetic acid, 1-(4-Chlorobenzoyl)-2-methyl-5-methoxyindole-3-acetic acid, 1-(p-Chlorobenzoyl)-2-methyl-5-methoxy-3-indole-acetic acid, 1-(p-chlorobenzoyl)-2-methyl-5-methoxy-3-indolylacetic acid, 1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indol acetic acid, Indomethacin, European Pharmacopoeia (EP) Reference Standard, N-(p-Chlorobenzoyl)-2-methyl-5-methoxy-3-indolylacetic acid, Indomethacin, United States Pharmacopeia (USP) Reference Standard, .alpha.-(1-(p-Chlorobenzoyl)-2-methyl-5-methoxy-3-indolyl)acetic acid, [1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetic acid #, 1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid & MAP-30, 1H-Indole-3-acetic acid, 1-(4-chlorobenzoyl)-5-methoxy-2-methyl- (9CI), 2-{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2 methylindol-3-yl}acetic acid, 2-{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2methylindol-3-yl}acetic acid, Indole-3-acetic acid, 1-(p-chlorobenzoyl)-5-methoxy-2-methyl- (8CI), Indomethacin, Pharmaceutical Secondary Standard; Certified Reference Material
Pubchem:PUBCHEM:3715
Id:1c24893c-a850-5753-930c-4dafa1c3dfa7
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Indomethacin's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Indomethacin.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Indomethacin.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.